door admin | feb 5, 2026 | news
*Seminar Alert!* Registration is now open for our February Seminar! Topic: “SERENITY: developing an evidence-based decision support tool to support shared decisions about continuing or discontinuing antithrombotic medication for people with cancer towards the...
door admin | jan 12, 2026 | news
We are developing a decision support tool We are developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi...
door admin | dec 12, 2025 | news
Serenity joins the Quality of Life and Patient-Centred Care (QoL-PCC) cluster The cluster represents a key opportunity to advance oncology care. One of the main goals is to develop a unified vision around these concepts while establishing core axes related to Patient...
door admin | okt 12, 2025 | news
WP4: Delphi Process Through this Delphi study, the following aspects will be defined:Β characterisation of candidate patients for discussion about ATT deprescribing healthcare team roles in ATT decision-making specific information and communication requirements for...
door admin | sep 12, 2025 | news
Who am I to stop taking my medication? Who am I to stop taking my medication – π’ π±π’π΅πͺπ¦π―π΅ π’π΄π¬π¦π₯ πͺπ― π°πΆπ³ π³π¦π€π¦π―π΅ π΄π΅πΆπ₯πΊ.When we as professionals want to stop medication, we often focus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.All true β...
